Industry Outlook

The antimicrobial susceptibility test market had market size of US$ 2885.42 Mn in 2021 and will grow at a CAGR 4.7% and is anticipated to reach US$ 4354.68 Mn in 2030. World Health Organization (WHO) has stipulated stringent guidelines to life science industry and agriculturists to judiciously use antibiotics. Rising prevalence of infectious disease and looming threat of superbug infection drives the antimicrobial susceptibility market growth. 

"Availability of diverse range of test kits and easy interpretation propel its market growth"

Tests and Kits are presently reigning the product segment for antimicrobial susceptibility test market. Availability of diverse range of test kits and increasing health awareness regarding infectious disease resulting in early screening drive the tests and kits market growth. They are available as point of care diagnostic kits where in interpretation of results are quick and product is highly reliable and cost saving. There will be burgeoning requirement for culture media on account of flourishing biopharmaceutical industry and preservation of important cell lines and culture having therapeutic significance.

"Increasing demand from clinical and epidemiology applications drive the disk diffusion method"

In the current scenario the disk diffusion method lead the method segment for antimicrobial susceptibility test market owing to its ability to determine the therapeutic efficacy and sensitivity of antibiotics towards different strains of bacteria. Increasing demand from clinical and epidemiological applications drive the market growth for disk diffusion method. Broth dilution method is gaining huge traction from food industry segment due to its potential to detect infection caused by microbes such as E.coli and Enterococcus.

"Rising prevalence of infectious disease and increasing number of patients suffering with antimicrobial resistance propel the antibacterial test market growth"

In the present scenario antibacterial test are dominating the test segment for antimicrobial susceptibility test market. The primary factors responsible for its dominance are rising prevalence of bacterial infection and increasing number of patients suffering with antimicrobial resistance. Scientist are striving earnestly to develop broad spectrum antibiotics. Antiparasitic tests will gain huge traction during the forecast period on account of huge health burden caused by parasitic infections such as malaria, dengue and encephalitis etc.

"Increasing public health awareness regarding infectious disease propel the clinical diagnosis market growth"

Clinical diagnosis is currently leading the application segment for antimicrobial susceptibility test market. The major factors that propel the clinical diagnosis market growth are increasing public health awareness regarding infectious disease resulting in early screening. Huge investment spend by government healthcare agencies worldwide to provide effective diagnosis and precise treatment to curb the diagnosed infection. Drug discovery and development will showcase positive growth owing to the increasing threat caused by antibiotic resistance and rising demand for vaccines and biologics as a preventive measure against deadly infections.

"Rising prevalence of bacterial infection and increasing number of cases pertaining to antibiotic resistance will support the market growth in Asia Pacific region"

North America is leading the regional segment for antimicrobial susceptibility test market. According to the latest research citing presented by Center for Disease Control and Prevention (CDC) annually 2 million U.S. citizens are diagnosed with infectious disease resulting in death of approximately 25,000 people. Existence of well-developed healthcare infrastructure drive the market growth in North America. Supportive regulatory environment provided by European Medical Agency (EMA) and looming threat of antimicrobial resistance drive the market growth in Europe region. Asia Pacific serves as a lucrative market on account of rising prevalence of bacterial infection and burgeoning requirement for broad spectrum antibiotics to curb the spread of infectious diseases.

Pharmaceutical companies providing diagnostic kits for antimicrobial susceptibility test are Alifax Holding S.p.A., Bio-Rad Laboratories, Inc., bioMerieux, Biotron Healthcare, Becton Dickinson & Company, Danaher Corporation, HiMedia, Laboratories, Merck Group, Synbiosis and Thermo Fisher Scientific, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Antimicrobial Susceptibility Test market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Antimicrobial Susceptibility Test market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Antimicrobial Susceptibility Test market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Antimicrobial Susceptibility Test market?
• Which is the largest regional market for Antimicrobial Susceptibility Test market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Antimicrobial Susceptibility Test market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Antimicrobial Susceptibility Test market worldwide?